# Potential Biological Processes Related to Brain SLC13A5 Across the Lifespan: Weighted Gene Co-Expression Network Analysis from Large Human Transcriptomic Data

**Authors:** Bruna Klippel Ferreira, Patricia Fernanda Schuck, Gustavo Costa Ferreira, Hércules Rezende Freitas

PMC · DOI: 10.3390/brainsci16020163 · Brain Sciences · 2026-01-30

## TL;DR

This study explores how the SLC13A5 gene, linked to brain disorders, changes across human development and identifies related biological processes in the brain.

## Contribution

The study reveals a mitochondria-centered gene network co-varying with SLC13A5 across the human lifespan.

## Key findings

- SLC13A5 expression peaks in the first postnatal year in the cerebrum and increases in the cerebellum across the lifespan.
- SLC13A5 is part of a gene module strongly associated with brain maturation and mitochondrial function.
- A subnetwork of genes closely connected to SLC13A5 includes CYP46A1, ITM2B, and others involved in oxidative phosphorylation.

## Abstract

Background/Objectives: SLC13A5 encodes a sodium–citrate cotransporter implicated in early-onset epileptic encephalopathy and metabolic brain dysfunction, yet its developmental regulation and molecular context in the human brain remain incompletely defined. Methods: Leveraging human developmental transcriptomes from the Evo-Devo resource, we delineated tissue trajectories and network context for SLC13A5 across the fetal–postnatal life. Results: In the cerebrum, SLC13A5 expression rises from late fetal stages to peak in the first postnatal year and then declines into adulthood, while cerebellar levels increase across the lifespan; liver shows a fetal decrease followed by sustained postnatal upregulation. A transcriptome-wide scan identified extensive positive and negative associations with SLC13A5, and a signed weighted gene co-expression network analysis (WGCNA) built on biweight midcorrelation placed SLC13A5 in a large module. The module eigengene tracked brain maturation (Spearman rho = 0.802, p = 8.62 × 10−6) and closely matched SLC13A5 abundance (rho = 0.884, p = 2.73 × 10−6), with a significant partial association after adjusting for developmental rank (rho = 0.672, p = 6.17 × 10−4). Functional enrichment converged on oxidative phosphorylation and mitochondria. A force-directed subnetwork of the top intramodular members (|bicor| > 0.6) positioned SLC13A5 adjacent to a densely connected nucleus including CYP46A1, ITM2B, NRGN, GABRD, FBXO2, CHCHD10, CYSTM1, and MFSD4A. Conclusions: Together, these results define a developmentally tuned, mitochondria-centered program that co-varies with SLC13A5 in the human brain across the lifespan. It may provide insights to interrogate age-dependent phenotypes and therapeutic avenues for disorders involving citrate metabolism.

## Linked entities

- **Genes:** SLC13A5 (solute carrier family 13 member 5) [NCBI Gene 284111], CYP46A1 (cytochrome P450 family 46 subfamily A member 1) [NCBI Gene 10858], ITM2B (integral membrane protein 2B) [NCBI Gene 9445], NRGN (neurogranin) [NCBI Gene 4900], GABRD (gamma-aminobutyric acid type A receptor subunit delta) [NCBI Gene 2563], FBXO2 (F-box protein 2) [NCBI Gene 26232], CHCHD10 (coiled-coil-helix-coiled-coil-helix domain containing 10) [NCBI Gene 400916], CYSTM1 (cysteine rich transmembrane module containing 1) [NCBI Gene 84418], SLC60A1 (solute carrier family 60 member 1) [NCBI Gene 148808]

## Full-text entities

- **Genes:** CA4 (carbonic anhydrase 4) [NCBI Gene 762] {aka CAIV, Car4, RP17}, TFAM (transcription factor A, mitochondrial) [NCBI Gene 7019] {aka MTDPS15, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2}, CHRNA4 (cholinergic receptor nicotinic alpha 4 subunit) [NCBI Gene 1137] {aka BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4}, LYNX1 (Ly6/neurotoxin 1) [NCBI Gene 66004], TESC (tescalcin) [NCBI Gene 54997] {aka CHP3, TSC}, SLC60A1 (solute carrier family 60 member 1) [NCBI Gene 148808] {aka MFSD4, MFSD4A, UNQ3064}, RGS4 (regulator of G protein signaling 4) [NCBI Gene 5999] {aka RGP4, SCZD9}, ICAM5 (intercellular adhesion molecule 5) [NCBI Gene 7087] {aka TLCN, TLN}, JUNB (JunB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3726] {aka AP-1}, TBXT (T-box transcription factor T) [NCBI Gene 6862] {aka SAVA, T, TFT}, CA11 (carbonic anhydrase 11 (inactive)) [NCBI Gene 770] {aka CA-RP, CA-RP II, CA-XI, CARP-2, CARPX1}, Slc13a5 (solute carrier family 13 (sodium-dependent citrate transporter), member 5) [NCBI Gene 237831] {aka Indy, NaC2/NaCT, Nact, mINDY}, TAMALIN (trafficking regulator and scaffold protein tamalin) [NCBI Gene 160622] {aka GRASP}, NRGN (neurogranin) [NCBI Gene 4900] {aka RC3, hng}, FBXO2 (F-box protein 2) [NCBI Gene 26232] {aka FBG1, FBX2, Fbs1, NFB42, OCP1}, NFE2 (nuclear factor, erythroid 2) [NCBI Gene 4778] {aka NF-E2, p45}, SLC13A5 (solute carrier family 13 member 5) [NCBI Gene 284111] {aka DEE25, EIEE25, INDY, NACT, mIndy}, CORO6 (coronin 6) [NCBI Gene 84940] {aka ClipinE}, CYP46A1 (cytochrome P450 family 46 subfamily A member 1) [NCBI Gene 10858] {aka CP46, CYP46}, CYSTM1 (cysteine rich transmembrane module containing 1) [NCBI Gene 84418] {aka C5orf32, ORF1-FL49}, GABRD (gamma-aminobutyric acid type A receptor subunit delta) [NCBI Gene 2563] {aka EIG10, EJM7, GABAARdelta, GEFSP5}, ITM2B (integral membrane protein 2B) [NCBI Gene 9445] {aka ABRI, BRI, BRI2, BRICD2B, E25B, E3-16}, ELF1 (E74 like ETS transcription factor 1) [NCBI Gene 1997] {aka EFTUD1, RIA1}, LDHD (lactate dehydrogenase D) [NCBI Gene 197257] {aka DLACD}, BACH2 (BACH transcriptional regulator 2) [NCBI Gene 60468] {aka BTBD25, IMD60}, ABCC3 (ATP binding cassette subfamily C member 3) [NCBI Gene 8714] {aka ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2}, COL5A3 (collagen type V alpha 3 chain) [NCBI Gene 50509], CHCHD10 (coiled-coil-helix-coiled-coil-helix domain containing 10) [NCBI Gene 400916] {aka C22orf16, FTDALS2, IMMD, MIX17A, N27C7-4, SMAJ}, AIFM3 (AIF family member 3) [NCBI Gene 150209] {aka AIFL}, TUBA4A (tubulin alpha 4a) [NCBI Gene 7277] {aka ALS22, CMYO26, FTDALS9, H2-ALPHA, OZEMA23, SPAX11}
- **Diseases:** type I diabetes (MESH:D003922), kidney disease (MESH:D007674), cognitive deficits (MESH:D003072), status epilepticus (MESH:D013226), communication and movement disorders (MESH:D003147), movement disorder (MESH:D009069), impaired motor function (MESH:D000068079), developmental epileptic encephalopathy 25 (OMIM:615905), progeria (MESH:D011371), autosomal recessive disease (MESH:D030342), Fragile X Syndrome (MESH:D005600), seizure (MESH:D012640), metabolic (MESH:D008659), Tooth hypoplasia (MESH:D014076), developmental delay (MESH:D002658), brain dysfunction (MESH:D001927), Parkinson's (MESH:D010300), neurodegeneration (MESH:D019636), injury to (MESH:D014947), inflammation (MESH:D007249), epilepsies (MESH:D004827), hyperlipidemia (MESH:D006949), amelogenesis imperfecta (MESH:D000567), rheumatoid arthritis (MESH:D001172), metabolic syndrome (MESH:D024821), autistic-like behaviors (MESH:D001321), febrile seizures (MESH:D003294), insulin resistance (MESH:D007333), Alzheimer's (MESH:D000544), non-alcoholic fatty liver disease (MESH:D065626), Huntington's disease (MESH:D006816), cancer (MESH:D009369)
- **Chemicals:** lipid (MESH:D008055), carbamazepine (MESH:D002220), ATP (MESH:D000255), citrate (MESH:D019343), phenobarbital (MESH:D010634), cholesterol (MESH:D002784), calcium (MESH:D002118), benzodiazepines (MESH:D001569), antiseizure medications (-), phenytoin (MESH:D010672)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938670/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938670/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938670/full.md

---
Source: https://tomesphere.com/paper/PMC12938670